An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance

Journal of Controlled Release

Volumn 208, Issue , 2015, Pages 42-51

  Liao, Zi Xian ^a   Chuang, Er Yuan ^b   Lin, Chia Chen ^b   Ho, Yi Cheng ^c   Lin, Kun Ju ^d,e   Cheng, Po Yuan ^b   Chen, Ko Jie ^b   Wei, Hao Ji ^f,g   Sung, Hsing Wen ^b  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Cancer therapy; Doxorubicin; Multidrug resistance; Receptor mediated endocytosis; Thermoresponsive liposomes

Indexed keywords

AMMONIUM BICARBONATE; CARBON DIOXIDE; CELLS; CHEMOTHERAPY; CYTOLOGY; DISEASES; DRUG THERAPY; ENZYME ACTIVITY; LIPID BILAYERS; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; ONCOLOGY; TUMORS;

CANCER THERAPY; DOXORUBICIN; MULTIDRUG RESISTANCE; RECEPTOR-MEDIATED ENDOCYTOSIS; THERMO-RESPONSIVE;

LIPOSOMES;

AGRO 100; AMMONIUM BICARBONATE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; BICARBONATE; DOXORUBICIN; LIPID BILAYER; LIPOSOME; NUCLEOLIN; OLIGODEOXYRIBONUCLEOTIDE; PEPTIDE APTAMER; PHOSPHOPROTEIN; RNA BINDING PROTEIN;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; LIPID BILAYER; MICROBUBBLE; MOUSE; MULTIDRUG RESISTANCE; NUDE MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APTAMERS, PEPTIDE; BICARBONATES; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LIPID BILAYERS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROBUBBLES; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHOPROTEINS; RNA-BINDING PROTEINS;

EID: 84938544203     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.01.032     Document Type: Article

References (42)

1. L.W. Fu, Y.M. Zhang, Y.J. Liang, X.P. Yang, and Q.C. Pan The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/ADR cells Eur. J. Cancer 38 2002 418 426
2. Y. Barenholz Doxil® - the first FDA-approved nano-drug: lessons learned J. Control. Release 160 2012 117 134
3. X. Li, Q. Zhao, and L. Qiu Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy J. Control. Release 171 2013 152 162
4. T.A. Elbayoumi, and V.P. Torchilin Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody Clin. Cancer Res. 15 2009 1973 1980
5. D. Pornpattananangkul, S. Olson, S. Aryal, M. Sartor, C.M. Huang, K. Vecchio, and L. Zhang Stimuli-responsive liposome fusion mediated by gold nanoparticles ACS Nano 4 2010 1935 1942
6. K. Maruyama Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects Adv. Drug Deliv. Rev. 63 2011 161 169
7. M.K. Danquah, X.A. Zhang, and R.I. Mahato Extravasation of polymeric nanomedicines across tumor vasculature Adv. Drug Deliv. Rev. 63 2011 623 639
8. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 2004 1818 1822
9. G.L. Plosker Pegylated liposomal doxorubicin: a review of its use in the treatment of relapsed or refractory multiple myeloma Drugs 68 2008 2535 2551
10. K.M. Laginha, S. Verwoert, G.J. Charrois, and T.M. Allen Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors Clin. Cancer Res. 11 2005 6944 6949
11. K.J. Chen, H.F. Liang, H.L. Chen, Y. Wang, P.Y. Cheng, H.L. Liu, Y. Xia, and H.W. Sung A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery ACS Nano 7 2013 438 446
12. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 1993 201 215
13. C.D. Landon, J.Y. Park, D. Needham, and M.W. Dewhirst Nanoscale drug delivery and hyperthermia: the materials design and preclinical and clinical testing of low temperature-sensitive liposomes used in combination with mild hyperthermia in the treatment of local cancer Open Nanomed. J. 3 2011 38 64
14. 2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis Angew. Chem. Int. Ed. 51 2012 10089 10093
15. S. Soundararajan, W. Chen, E.K. Spicer, N. Courtenay-Luck, and D.J. Fernandes The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells Cancer Res. 68 2008 2358 2365
16. A. Aravind, P. Jeyamohan, R. Nair, S. Veeranarayanan, Y. Nagaoka, Y. Yoshida, T. Maekawa, and D.S. Kumar AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery Biotechnol. Bioeng. 109 2012 2920 2931
17. P.J. Patty, and B.J. Frisken The pressure-dependence of the size of extruded vesicles Biophys. J. 85 2003 996 1004
18. D. Peters, M. Kastantin, V.R. Kotamraju, P.P. Karmali, K. Gujraty, M. Tirrell, and E. Ruoslahti Targeting atherosclerosis by using modular, multifunctional micelles Proc. Natl. Acad. Sci. U. S. A. 106 2009 9815 9819
19. J. Takasaki, and S.M. Ansell Micelles as intermediates in the preparation of protein-liposome conjugates Bioconjug. Chem. 17 2006 438 450
20. M.T. Nelson, W. Humphrey, A. Gursoy, A. Dalke, L.V. Kale, R.D. Skeel, and K. Schulten NAMD: a parallel, object oriented molecular dynamics program Int. J. High Perform. Comput. Appl. 10 1996 251 268
21. B.R. Brooks, R.E. Bruccoleri, B.D. Olafson, D.J. States, S. Swaminathan, and M. Karplus CHARMM: a program for macromolecular energy, minimization, and dynamics calculations J. Comput. Chem. 4 1983 187 217
22. W. Jiang, and B. Roux Free energy perturbation Hamiltonian replica-exchange molecular dynamics (FEP/H-REMD) for absolute ligand binding free energy calculations J. Chem. Theory Comput. 6 2010 2559 2565
23. L.W. Hsu, Y.C. Ho, E.Y. Chuang, C.T. Chen, J.H. Juang, F.Y. Su, S.M. Hwang, and H.W. Sung Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions Biomaterials 34 2013 784 793
24. C.J. Ke, W.L. Chiang, Z.X. Liao, H.L. Chen, P.S. Lai, J.S. Sun, and H.W. Sung Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance Biomaterials 34 2013 1 10
25. K.J. Chen, E.Y. Chuang, S.P. Wey, K.J. Lin, F. Cheng, C.C. Lin, H.L. Liu, H.W. Tseng, C.P. Liu, M.C. Wei, C.M. Liu, and H.W. Sung Hyperthermia-mediated local drug delivery by a bubble-generating liposomal system for tumor-specific chemotherapy ACS Nano 8 2014 5105 5115
26. G.A. Koning, A.M. Eggermont, L.H. Lindner, and T.L. Ten Hagen Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors Pharm. Res. 27 2010 1750 1754
27. R.W. Ahn, F. Chen, H. Chen, S.T. Stern, J.D. Clogston, A.K. Patri, M.R. Raja, E.P. Swindell, V. Parimi, V.L. Cryns, and T.V. O'Halloran A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer Clin. Cancer Res. 16 2010 3607 3617
28. B. Min, I.Y. Bae, H.G. Lee, S.H. Yoo, and S. Lee Utilization of pectin-enriched materials from apple pomace as a fat replacer in a model food system Bioresour. Technol. 101 2010 5414 5418
29. Y. Yang, N. Bajaj, P. Xu, K. Ohn, M.D. Tsifansky, and Y. Yeo Development of highly porous large PLGA microparticles for pulmonary drug delivery Biomaterials 30 2009 1947 1953
30. 2-"neutral" hydrogen storage based on bicarbonates and formates Angew. Chem. Int. Ed. 50 2011 6411 6414
31. S.L. Huang Liposomes in ultrasonic drug and gene delivery Adv. Drug Deliv. Rev. 60 2008 1167 1176
32. D. Liu, L.M. Bimbo, E. Makila, F. Villanova, M. Kaasalainen, B. Herranz-Blanco, C.M. Caramella, V.P. Lehto, J. Salonen, K.H. Herzig, J. Hirvonen, and H.A. Santos Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles J. Control. Release 170 2013 268 278
33. M.N. Davies, C.E. Sansom, C. Beazley, and D.S. Moss A novel predictive technique for the MHC class II peptide-binding interaction Mol. Med. 9 2003 220 225
34. S. Soundararajan, L. Wang, V. Sridharan, W. Chen, N. Courtenay-Luck, D. Jones, E.K. Spicer, and D.J. Fernandes Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells Mol. Pharmacol. 76 2009 984 991
35. B.L. Zhang, Z. Luo, J.J. Liu, X.W. Ding, J.H. Li, and K.Y. Cai Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo J. Control. Release 192 2014 192 201
36. D. Pozzi, V. Colapicchioni, G. Caracciolo, S. Piovesana, A.L. Capriotti, S. Palchetti, S. De Grossi, A. Riccioli, H. Amenitsch, and A. Lagana Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells Nanoscale 6 2014 2782 2792
37. 4 nanoparticles for reduced non-specific uptake by macrophage cells Adv. Mater. 19 2007 3163 3166
38. D.C. Drummond, O. Meyer, K.L. Hong, D.B. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 743
39. K. Shao, Q.S. Hou, W. Duan, M.L. Go, K.P. Wong, and Q.T. Li Intracellular drug delivery by sulfatide-mediated liposomes to gliomas J. Control. Release 115 2006 150 157
40. T.M. Suter, and M.S. Ewer Cancer drugs and the heart: importance and management Eur. Heart J. 34 2013 1102 1111
41. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763
42. 18F-FDG J. Nucl. Med. 44 2003 1426 1431